HOOKIPA Pharma's Return On Capital Employed Insights

By: via Benzinga
According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.